{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:00:09Z","timestamp":1774119609092,"version":"3.50.1"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1164\/rccm.201303-0470up","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T15:14:19Z","timestamp":1372691659000},"page":"23-28","source":"Crossref","is-referenced-by-count":4,"title":["Update in Pulmonary Vascular Diseases 2012"],"prefix":"10.1093","volume":"188","author":[{"given":"Martin R.","family":"Wilkins","sequence":"first","affiliation":[{"name":"Centre for Pharmacology and Therapeutics, Department of Medicine, Imperial College London, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wharton","sequence":"additional","affiliation":[{"name":"Centre for Pharmacology and Therapeutics, Department of Medicine, Imperial College London, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Gladwin","sequence":"additional","affiliation":[{"name":"Department of Medicine and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"2026032100492249400_bib1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1164\/rccm.201203-0377UP","article-title":"Update in pulmonary vascular diseases 2011","volume":"185","author":"Hassoun","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib2","doi-asserted-by":"crossref","first-page":"1026A","DOI":"10.1378\/chest.1456207","article-title":"Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension (PAH): results from the SERAPHIN trial [abstract]","volume":"142","author":"Rubin","year":"2012","journal-title":"Chest"},{"key":"2026032100492249400_bib3","doi-asserted-by":"crossref","first-page":"1027A","DOI":"10.1378\/chest.1462799","article-title":"A randomized, double-blind, placebo-controlled study (PATENT-1) [abstract]","volume":"142","author":"Ghofrani","year":"2012","journal-title":"Chest"},{"key":"2026032100492249400_bib4","doi-asserted-by":"crossref","first-page":"1023A","DOI":"10.1378\/chest.1462924","article-title":"Riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: a randomized, double-blind, placebo-controlled study (CHEST-1) [abstract]","volume":"142","author":"Ghofrani","year":"2012","journal-title":"Chest"},{"key":"2026032100492249400_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","volume":"186","author":"Stacher","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1164\/rccm.201206-1049ED","article-title":"Progress in pulmonary arterial hypertension pathology: relighting a torch inside the tunnel","volume":"186","author":"Dorfm\u00fcller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","article-title":"Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland","volume":"186","author":"Ling","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.201207-1266ED","article-title":"Evolving epidemiology of pulmonary arterial hypertension","volume":"186","author":"Thenappan","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.00030312","article-title":"A potential role for insulin resistance in experimental pulmonary hypertension","volume":"41","author":"West","year":"2013","journal-title":"Eur Respir J"},{"key":"2026032100492249400_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"2026032100492249400_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1164\/rccm.201207-1290OC","article-title":"Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension","volume":"187","author":"Wu","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"2026032100492249400_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Dunham","year":"2012","journal-title":"Nature"},{"key":"2026032100492249400_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach","volume":"125","author":"Parikh","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.112.267591","article-title":"A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples","volume":"111","author":"Caruso","year":"2012","journal-title":"Circ Res"},{"key":"2026032100492249400_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.201106-1093OC","article-title":"Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension","volume":"185","author":"Pullamsetti","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.111.258426","article-title":"Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism","volume":"110","author":"Cavasin","year":"2012","journal-title":"Circ Res"},{"key":"2026032100492249400_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1183\/09031936.00159911","article-title":"Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension","volume":"40","author":"Huertas","year":"2012","journal-title":"Eur Respir J"},{"key":"2026032100492249400_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/CIRCULATIONAHA.112.110619","article-title":"Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension","volume":"126","author":"Ormiston","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201204-0609ED","article-title":"Injection drug use as a \u201csecond hit\u201d in the pathogenesis of HIV-associated pulmonary hypertension","volume":"185","author":"George","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/rccm.201110-1909OC","article-title":"Enhanced pulmonary arteriopathy in simian immunodeficiency virus\u2013infected macaques exposed to morphine","volume":"185","author":"Spikes","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1165\/rcmb.2011-0434OC","article-title":"Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension","volume":"48","author":"George","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032100492249400_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1164\/rccm.201202-0309OC","article-title":"A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents","volume":"186","author":"Tu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCRESAHA.112.266361","article-title":"Enhanced Ca2+-sensing receptor function in idiopathic pulmonary arterial hypertension","volume":"111","author":"Yamamura","year":"2012","journal-title":"Circ Res"},{"key":"2026032100492249400_bib28","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1210\/en.2012-1780","article-title":"Corticosteroids, heart failure, and hypertension: a role for immune cells?","volume":"153","author":"Shen","year":"2012","journal-title":"Endocrinology"},{"key":"2026032100492249400_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.201208-1480ED","article-title":"TrACEing angiotensin II type 1 to right ventricular hypertrophy: are the \u201csartans\u201d a viable course to treating pulmonary arterial hypertension?","volume":"186","author":"Ranayhossaini","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","article-title":"Dysregulated renin\u2013angiotensin\u2013aldosterone system contributes to pulmonary arterial hypertension","volume":"186","author":"de Man","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","article-title":"Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1183\/09031936.00010409","article-title":"Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females","volume":"34","author":"Austin","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032100492249400_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/01.fjc.0000175878.32920.17","article-title":"Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats","volume":"46","author":"Tofovic","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026032100492249400_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1164\/rccm.201201-0058PP","article-title":"Estrogen paradox in pulmonary hypertension: current controversies and future perspectives","volume":"186","author":"Umar","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201107-1293OC","article-title":"17\u03b2-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor\u2013mediated effects","volume":"185","author":"Lahm","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1164\/rccm.201203-0480OC","article-title":"The minimal important difference in the 6-Minute Walk Test for patients with pulmonary arterial hypertension","volume":"186","author":"Mathai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCULATIONAHA.112.105890","article-title":"Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials","volume":"126","author":"Gabler","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/rccm.201206-1137ED","article-title":"The 6-Minute Walk Test in pulmonary arterial hypertension: how far is enough?","volume":"186","author":"Rubin","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.201105-0848OC","article-title":"Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension","volume":"185","author":"Minai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1164\/rccm.201112-2178ED","article-title":"Drumming up prognostic significance in a heartbeat in pulmonary arterial hypertension","volume":"185","author":"Hassoun","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ahj.2012.01.023","article-title":"Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis","volume":"163","author":"Ramos","year":"2012","journal-title":"Am Heart J"},{"key":"2026032100492249400_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.201110-1860OC","article-title":"Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: a pressure\u2013volume relationship study","volume":"186","author":"Kasner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in adults with sickle cell disease and pulmonary hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"key":"2026032100492249400_bib44","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/rccm.201207-1222OC","article-title":"Hemodynamic predictors of mortality in adults with sickle cell disease","volume":"187","author":"Mehari","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1148\/radiol.12111001","article-title":"Pulmonary arterial hypertension: MR imaging\u2013derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling","volume":"263","author":"Skrok","year":"2012","journal-title":"Radiology"},{"key":"2026032100492249400_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1148\/radiol.12111599","article-title":"Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study","volume":"266","author":"Shehata","year":"2013","journal-title":"Radiology"},{"key":"2026032100492249400_bib47","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.0605080104","article-title":"Alterations of cellular bioenergetics in pulmonary artery endothelial cells","volume":"104","author":"Xu","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026032100492249400_bib48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/rccm.201108-1562OC","article-title":"Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension","volume":"185","author":"Marsboom","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2012","journal-title":"Eur Respir J"},{"key":"2026032100492249400_bib50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1164\/rccm.201205-0886OC","article-title":"Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension","volume":"186","author":"Larkin","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1164\/rccm.201209-1666ED","article-title":"Waiting in anticipation: the genetics of pulmonary arterial hypertension","volume":"186","author":"Aldred","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib52","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/CIRCULATIONAHA.112.106245","article-title":"Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance","volume":"126","author":"Cogan","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib53","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.112.135004","article-title":"Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystack","volume":"126","author":"White","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1165\/rcmb.2011-0251OC","article-title":"Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance","volume":"47","author":"Flynn","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032100492249400_bib55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1183\/09031936.00137511","article-title":"Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension","volume":"40","author":"Simonneau","year":"2012","journal-title":"Eur Respir J"},{"key":"2026032100492249400_bib56","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/CIRCULATIONAHA.112.100586","article-title":"Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase","volume":"125","author":"Baliga","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"2026032100492249400_bib58","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201210-1928PP","article-title":"Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension","volume":"187","author":"Abman","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100492249400_bib59","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/ATVBAHA.112.248500","article-title":"Role of Src tyrosine kinases in experimental pulmonary hypertension","volume":"32","author":"Pullamsetti","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026032100492249400_bib60","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","article-title":"Pulmonary arterial hypertension in patients treated by dasatinib","volume":"125","author":"Montani","year":"2012","journal-title":"Circulation"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/188\/1\/23\/67241103\/ajrccm_188_1_23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/188\/1\/23\/67241103\/ajrccm_188_1_23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:51:54Z","timestamp":1774068714000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/188\/1\/23\/8506952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,7,1]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201303-0470up","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,7]]},"published":{"date-parts":[[2013,7,1]]}}}